Patents by Inventor Avi Fischer
Avi Fischer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230411019Abstract: System for arrhythmia detection and confirmation includes implantable medical device (IMD) having a sensing circuit for sensing cardiac activity (CA) for one or more cardiac cycles and generating one or more CA signals. An implantable pressure sensor (IPS) includes IPS sensing circuit for sensing pressure during the one or more cardiac cycles and generating one or more pressure signals. IMD and IPS include communications circuits for communicating with each other and/or an external device. One or both of IMD or IPS includes memory for storing program instructions and processor(s) for analyzing one of the CA or pressure signals, for one or more cardiac cycles, to detect a candidate arrhythmia. In response to detecting candidate arrhythmia, the processor(s) obtain another one of CA or pressure signals for cardiac cycles corresponding to the one or more cardiac cycles, and confirm or deny candidate arrhythmia based on the other one of the signals.Type: ApplicationFiled: May 30, 2023Publication date: December 21, 2023Inventors: Jong Gill, Nima Badie, Kyungmoo Ryu, Avi Fischer, Philip B. Adamson
-
Publication number: 20230241402Abstract: A system and method are provided for managing atrial-ventricular (AV) delay adjustments. An AV interval is measured that corresponds to an interval between an atrial paced (Ap) event or an atrial sensed (As) event and a sensed ventricular (Vs) event. A candidate AV delay is set based on the AV interval and a bundle branch adjustment (BBA) value. A QRS characteristic of interest (COI) is measured while utilizing the candidate AV delay in connection with delivering a pacing therapy. The BBA value is adjusted and the candidate AV delay is reset based on the BBA value as adjusted. A collection of QRS COIs and corresponding candidate AV delays are obtained and one of the candidate AV delays is selected as a BBA AV delay. The pacing therapy is managed, based on the BBA AV delay.Type: ApplicationFiled: April 10, 2023Publication date: August 3, 2023Inventors: Wenwen Li, Nima Badie, Luke C. McSpadden, Yun Qiao, Avi Fischer, Kyungmoo Ryu
-
Patent number: 11654288Abstract: A system and method are provided for managing atrial-ventricular (AV) delay adjustments. An AV interval is measured that corresponds to an interval between an atrial paced (Ap) event or an atrial sensed (As) event and a sensed ventricular (Vs) event. A candidate AV delay is set based on the AV interval and a bundle branch adjustment (BBA) value. A QRS characteristic of interest (COI) is measured while utilizing the candidate AV delay in connection with delivering a pacing therapy. The BBA value is adjusted and the candidate AV delay is reset based on the BBA value as adjusted. A collection of QRS COIs and corresponding candidate AV delays are obtained and one of the candidate AV delays is selected as a BBA AV delay. The pacing therapy is managed, based on the BBA AV delay.Type: GrantFiled: August 10, 2020Date of Patent: May 23, 2023Assignee: Pacesetter, Inc.Inventors: Wenwen Li, Nima Badie, Luke C. McSpadden, Yun Qiao, Avi Fischer, Kyungmoo Ryu
-
Patent number: 11484705Abstract: Methods for implanting a pulse generator (PG) within a pectoral region of a chest of a patient and devices having the PG. The PG has a housing that includes a PG electrode. Methods also include implanting at least one lead having first and second electrode segments with the first electrode segment positioned along an anterior of the chest of the patient and the second electrode segment positioned along at least one of a posterior of the patient or a side of the patient. The first and second electrode segments are positioned subcutaneously at or below an apex of a heart of the patient, wherein the PG electrode and the first and second electrode segments are configured to provide electrical shocks for antiarrhythmic therapy.Type: GrantFiled: April 27, 2020Date of Patent: November 1, 2022Assignee: Pacesetter, Inc.Inventors: Xiaoyi Min, Avi Fischer, Kyungmoo Ryu, Gabriel A. Mouchawar
-
Publication number: 20220040484Abstract: A system and method for managing atrial-ventricular (AV) delay adjustments are provided and includes electrodes configured to be located proximate to an atrial (A) site and at least one of a left bundle branch (LBB) site or a HIS site. An IMD has a header that includes a right atrial (RA) header port, a right ventricular (RV) header port and a left ventricular (LV) header port. The system includes memory configured to store program instructions and one or more processors that, when configured to execute the program instructions measure an AV interval corresponding to an interval between an atrial paced (Ap) event or an atrial sensed (As) event and a sensed ventricular (Vs) event.Type: ApplicationFiled: August 10, 2020Publication date: February 10, 2022Inventors: Wenwen Li, Nima Badie, Luke C. McSpadden, Yun Qiao, Avi Fischer, Kyungmoo Ryu
-
Patent number: 11221373Abstract: Methods, devices and program products are provided for determining an early battery depletion condition for a battery powered device. The method determines a charge consumption drawn externally from a battery cell by the device for a select period of time, obtains a measured cell voltage for the battery cell of the medical device, calculates a projected cell voltage based on the charge consumption and usage conditions, and declares an early depletion condition based on a relation between the measured and projected cell voltages.Type: GrantFiled: June 23, 2017Date of Patent: January 11, 2022Assignee: PACESETTER, INC.Inventors: Avi Fischer, Gene A. Bornzin, Thomas F. Strange, Xing Pei, Aditya Goil, Fady Dawoud, Kyungmoo Ryu, Joseph Beauvais, Gabriel Mouchawar, Richard Williamson
-
Patent number: 11045643Abstract: Methods and devices include making an incision at a single site of a patient. The single site located at an anterior of a chest or abdomen. The method also includes inserting a tunneling tool through the incision at the single site and preparing a first tunnel to a subcutaneous posterior location. A path of the first tunnel at least one of i) extends over a plurality of Intercostal gaps of the chest or ii) extends along and within one of the intercostal gaps. The method also includes positioning a first lead having an electrode within the first tunnel and preparing a second tunnel to a subcutaneous parasternal location along the chest. The method also includes positioning a second lead having an electrode within the second tunnel and positioning a pulse generator within a subcutaneous pocket and operatively coupling the first and second leads to the pulse generator.Type: GrantFiled: May 7, 2018Date of Patent: June 29, 2021Assignee: Pacesetter, Inc.Inventors: Avi Fischer, Xiaoyi Min, Kyungmoo Ryu, Gene A. Bornzin, Keith Victorine, Stuart Rosenberg, Shubha Asopa
-
Publication number: 20200254238Abstract: Methods for implanting a pulse generator (PG) within a pectoral region of a chest of a patient and devices having the PG. The PG has a housing that includes a PG electrode. Methods also include implanting at least one lead having first and second electrode segments with the first electrode segment positioned along an anterior of the chest of the patient and the second electrode segment positioned along at least one of a posterior of the patient or a side of the patient. The first and second electrode segments are positioned subcutaneously at or below an apex of a heart of the patient, wherein the PG electrode and the first and second electrode segments are configured to provide electrical shocks for antiarrhythmic therapy.Type: ApplicationFiled: April 27, 2020Publication date: August 13, 2020Inventors: Xiaoyi Min, Avi Fischer, Kyungmoo Ryu, Gabriel A. Mouchawar
-
Patent number: 10722704Abstract: Methods for implanting a puke generator (PG) within a pectoral region of a chest of a patient and devices having the PG. The PG has a housing that includes a PG electrode. Methods also include implanting at least one lead having first and second electrode segments with the first electrode segment positioned along an anterior of the chest of the patient and the second electrode segment positioned along at least one of a posterior of the patient or a side of the patient. The first and second electrode segments are positioned subcutaneously at or below an apex of a heart of the patient, wherein the PG electrode and the first and second electrode segments are configured to provide electrical shocks for antiarrhythmic therapy.Type: GrantFiled: May 7, 2018Date of Patent: July 28, 2020Assignee: Pacesetter, Inc.Inventors: Xiaoyi Min, Avi Fischer, Kyungmoo Ryu, Gabriel A. Mouchawar
-
Publication number: 20190336754Abstract: Methods for implanting a puke generator (PG) within a pectoral region of a chest of a patient and devices having the PG. The PG has a housing that includes a PG electrode. Methods also include implanting at least one lead having first and second electrode segments with the first electrode segment positioned along an anterior of the chest of the patient and the second electrode segment positioned along at least one of a posterior of the patient or a side of the patient. The first and second electrode segments are positioned subcutaneously at or below an apex of a heart of the patient, wherein the PG electrode and the first and second electrode segments are configured to provide electrical shocks for antiarrhythmic therapy.Type: ApplicationFiled: May 7, 2018Publication date: November 7, 2019Applicant: Pacesetter, Inc.Inventors: Xiaoyi Min, Avi Fischer, Kyungmoo Ryu, Gabriel A. Mouchawar
-
Publication number: 20190336747Abstract: Methods and devices include making an incision at a single site of a patient. The single site located at an anterior of a chest or abdomen. The method also includes inserting a tunneling tool through the incision at the single site and preparing a first tunnel to a subcutaneous posterior location. A path of the first tunnel at least one of i) extends over a plurality of Intercostal gaps of the chest or ii) extends along and within one of the intercostal gaps. The method also includes positioning a first lead having an electrode within the first tunnel and preparing a second tunnel to a subcutaneous parasternal location along the chest. The method also includes positioning a second lead having an electrode within the second tunnel and positioning a pulse generator within a subcutaneous pocket and operatively coupling the first and second leads to the pulse generator.Type: ApplicationFiled: May 7, 2018Publication date: November 7, 2019Applicant: Pacesetter, Inc.Inventors: Avi Fischer, Xiaoyi Min, Kyungmoo Ryu, Gene A. Bornzin, Keith Victorine, Stuart Rosenberg, Shubha Asopa
-
Publication number: 20180372805Abstract: Methods, devices and program products are provided for determining an early battery depletion condition for a battery powered device. The method determines a charge consumption drawn externally from a battery cell by the device for a select period of time, obtains a measured cell voltage for the battery cell of the medical device, calculates a projected cell voltage based on the charge consumption and usage conditions, and declares an early depletion condition based on a relation between the measured and projected cell voltages.Type: ApplicationFiled: June 23, 2017Publication date: December 27, 2018Inventors: Avi Fischer, Gene A. Bornzin, Thomas F. Strange, Xing Pei, Aditya Goil, Fady Dawoud, Kyungmoo Ryu, Joseph Beauvais, Gabriel Mouchawar, Richard Williamson
-
Patent number: 9216285Abstract: A leadless implantable medical device (IMD) may include an electrode, a housing, and an energy transfer component. The housing retains a pulse generator configured to provide stimulation energy for delivery to a tissue of interest, a power supply, a memory storing programmable instructions, and a processor communicatively coupled to the memory. The processor is responsive to the programmable instructions to control operation of the leadless IMD. The electrode is securely affixed to the tissue of interest. The housing includes first and second body portions mated to one another at a detachable interface. The electrode is coupled to the second body portion. The energy transfer component is distributed between the first and second body portions and is configured to convey at least one of stimulation energy or sensed signals across the detachable interface when the first and second body portions are mated to one another.Type: GrantFiled: December 18, 2014Date of Patent: December 22, 2015Assignee: Pacesetter, Inc.Inventors: Carl Lance Boling, Gene A. Bornzin, Yelena Nabutovsky, Avi Fischer
-
Publication number: 20140350623Abstract: Techniques are provided for use with implantable devices equipped with programmable voltage multipliers (including voltage dividers.) Candidate pulse widths are determined for selected voltage multipliers and stimulation vectors. Each candidate pulse width corresponds to a lowest pulse energy sufficient to achieve capture within the tissues of the patient (subject to a safety margin) using the selected vector and using the corresponding voltage multiplier. As such, a candidate pulse width represents a preferred or optimal pulse width, at least insofar as energy consumption is concerned. However, depending upon the capabilities of the device, the candidate pulse width might not be achievable. Accordingly, for each programmable vector, the system determines a lowest “operable” voltage multiplier sufficient to generate a pulse at a candidate pulse width subject to the capabilities of the device.Type: ApplicationFiled: May 24, 2013Publication date: November 27, 2014Applicant: PACESETTER, INC.Inventors: Avi Fischer, Bryan Tilton, Gene A. Bornzin